27 results
8-K
EX-99.2
6gvxxny2v
8 Aug 22
REATA PHARMACEUTICALS, INC. ANNOUNCES Second QUARTER 2022 FINANCIAL
6:45am
8-K
EX-99.1
fpge9f
1 Mar 21
Reata pharmaceuticals, inc. announces FOURTH quarter AND FULL YEAR 2020 financial RESULTS and provides an update on CLINICAL DEVELOPMENT programs
6:40am
8-K
EX-99.1
8h0bykf5
11 Jan 21
Regulation FD Disclosure
6:30am
424B5
ft9gs4fwte9lg53
3 Dec 20
Prospectus supplement for primary offering
4:41pm
424B5
gv098enf76lvpqa7
1 Dec 20
Prospectus supplement for primary offering
4:17pm
8-K
EX-99.1
o0gzs
9 Nov 20
Vinny Jindal; Reata Pharmaceuticals Inc.; VP of Strategy
5:30pm
8-K
EX-99.3
3qlhe1jo
9 Nov 20
Reported positive year 2 data from the pivotal CARDINAL study of bardoxolone methyl in patients with chronic kidney disease caused by Alport syndrome
6:51am